The model used in the study achieved an area under the curve (AUC) of 0.76 and showed the potential for evaluating the risk of recurrence and metastasis in patients with human epidermal growth factor receptor 2 (HER2)-positive breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.